Expression of brain-derived neurotrophic factor (BDNF) and inducible nitric oxide synthase (iNOS) in rat astrocyte cultures treated with Levetiracetam

Brain Research

Volumn 976, Issue 2, 2003, Pages 227-233

  Cardile, Venera ^a   Pavone, Antonino ^b   Gulino, Rosario ^a   Renis, Marcella ^a   Scifo, Christian ^a   Perciavalle, Vincenzo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b GARIBALDI HOSPITAL   (Italy)

Author keywords

Antiepileptic drug; Brain derived neurotrophic factor; Glial cell; Immunoblotting; Immunostaining; INOS; Levetiracetam

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ETIRACETAM; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; CONTROLLED STUDY; DRUG EFFECT; ENZYME ANALYSIS; GLIA CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT;

EID: 0038368100     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02720-3     Document Type: Article

References (26)

1. Althaus H.H., Richter-Landsbergt C.H. Glial cells as targets and producers of neurotrophins. Int. Rev. Cytol. 197:2000;203-277.
2. Araque A., Carmignoto G., Haydon P.G. Dynamic signaling between astrocytes and neurones. Annu. Rev. Physiol. 63:2001;795-813.
3. Binder D.K., Croll S.D., Gall C.M., Scharfman H.E. BDNF and epilepsy: too much of a good thing? Trends Neurosci. 24:2001;47-53.
4. Birnstiel S., Wulfert E., Beck S.G. Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission. Naunyn Schmiedebergs Arch. Pharmacol. 356:1997;611-618.
5. Blondel O., Collin C., McCarran W.J., Zhu S., Zamostiano R., Goses I., et al. A glia-derived signal regulating neuronal differentiation. J. Neurosci. 20:2000;8012-8020.
6. Blum R., Kafitz K.W., Konnerth A. Neurotrophin-evoked depolarization requires the sodium channel Na(V)1.9. Nature. 419:2002;687-693.
7. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye-binding. Anal. Biochem. 72:1976;248-254.
8. Calabrese V., Renis M., Calderone A., Russo A., Barcellona M.L., Rizza V. Stress proteins and SH-groups in oxidant-induced cell damage after acute ethanol administration in rat. Free Radic. Biol. Med. 20:1996;391-397.
9. Cardile V., Pavone A., Renis M., Russo A., Perciavalle V. Biological effects of tiagabine on primary cortical astrocyte cultures of rat. Neurosi. Lett. 288:2000;49-52.
10. Del-Bel E.A., Oliveira J.A., Mishra P.-K.-. Anticonvulsant and proconvulsant roles of nitric oxide in experimental epilepsy models. Braz. J. Med. Biol. Res. 30:1997;971-979.
11. Doheny H.C., Ratnaraj N., Whittington M.A., Jefferys J.G., Patsalos P.N. Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (ucb L059) in the rat. Epilepsy Res. 34:1999;161-168.
12. Estévez A.G., Spear N., Manuel S.M., Radi R., Henderson C.E., Barbeito L., et al. Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J. Neurosci. 18:1998;923-931.
13. Estévez A.G., Kamaid A., Thompson J.A., Cornwell T.L., Radi R., Barbeito L., et al. Cyclic guanosine 5′monophosphate (GMP) prevents expression of neuronal nitric oxide synthase and apoptosis in motor neurons deprived of trophic factors in rats. Neurosci. Lett. 326:2002;201-205.
14. Estévez A.G., Spear N., Manuel S.M., Radi R., Barbeito L., Beckman J.S. Role of endogenous nitric oxide and peroxynytrite formation in the survival and death of motor neurons in culture. Mize R., Fredlander M. Progress in Brain Research. Vol. 118:1998;269-280 Elsevier, Amsterdam.
15. Hovinga C.A. Levetiracetam: a novel antiepileptic drug. Pharmacotherapy. 21:2001;1375-1388.
16. Kovalchuk Y., Hanse E., Kafitz K.W., Konnerth A. Postsynaptic induction of BDNF-mediated long-term potentiation. Science. 295:2002;1729-1734.
17. Kwan P., Sills G.J., Brodie M.J. The mechanisms of action of commonly used antiepileptic drugs. Pharmacol. Ther. 90:2001;21-34.
18. Laemnli U.K. Cleavage of the structural proteins during the assembly of the head of bacteriophage T4. Nature. 277:1970;680-685.
19. Margineanu D.G., Wulfert E. ucb L059, a novel anticonvulsant, reduces bicuculline-induced hyperexcitability in rat hippocampal CA3 in vivo. Eur. J. Pharmacol. 286:1995;321-325.
20. Pahan K., Sheikh F.G., Namboodiri A.M., Singh I. N-Acetyl cysteine inhibits induction of NO production by endotoxin or cytokine stimulated rat peritoneal macrophages C6 glial cells and astrocytes. Free Radic. Biol. Med. 24:1998;39-48.
21. Pascual M., Climent E., Guerri C. BDNF induces glutamate release in cerebrocortical nerve terminals and in cortical astrocytes. Neuroreport. 12:2001;2673-2677.
22. Poo M.M. Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2:2001;24-32.
23. Reibel S., Depaulis A. BDNF and epilepsy-the bad could turn out to be good. Trends Neurosci. 24:2001;318-319.
24. Smith S.E., Man P.K., Yip E. Anticonvulsant effects of 7-nitroindazin rodents with reflex epilepsy may result from L-arginine accumulation or reduction in nitric oxide or L-citrulline formation. Br. J. Pharmacol. 119:1996;165-173.
25. Ullian E.M., Sapperstein S.K., Christopherson K.S., Barres B.A. Control of synapse number by glia. Science. 291:2001;657-661.
26. Ward N.L., Hagg T. BDNF is needed for postnatal maturation of basal forebrain and neostriatum cholinergic neurons in vivo. Exp. Neurol. 162:2000;297-310.